¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö : 2023-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ¼ººÏ±¸ °í·Á´ë·Î 73 °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°ü 5Ãþ ¸ÞµðÈú Ȧ

±³À°ÁÖÁ¦ : 2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : °í·Á´ëÇб³¾È¾Ïº´¿ø
´ã´çÀÚ : ±èÁöÀº
¿¬¶ôó : 02-920-5690  

À̸ÞÀÏ : hoekumc@gmail.com

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 09:30~10:00 Currnet challeges of CAR T-cell therapy in adult B-cell lymphoma ±è¼®Áø(¼­¿ï»ï¼ºº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 10:00~10:30 CAR-T cell therapy and multiple myeloma º¯ÀÚ¹Î(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 10:30~11:00 Status and Challenges of CAR T-cell therapy in childhood cancer ±èÇý¸®(¼­¿ï¾Æ»êº´¿ø)

ÈÞ½Ä 11¿ù 11ÀÏ 11:00~11:20 ÈÞ½Ä ( )

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 11:20~11:50 CAR-T ¼¼Æ÷󸮸¦ À§ÇÑ ÀÎü¼¼Æ÷°ü¸®¾÷ Çã°¡ ¹× ³ë¹ÙƼ½º ÀÎÁõ ÀýÂ÷ Á¤ÇöÈ£(³ë¹ÙƼ½ºÄÚ¸®¾Æ)

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 11:50~12:20 CAR-T Ä¡·á¸¦ À§ÇÑ ÀÓ»ó ¿µ¿ªÀÇ Áغñ ¹× ÁÖÀÇ »çÇ× °­°¡¿ø(°í·Á´ëÇб³¾È¾Ïº´¿ø)

½Ä»ç 11¿ù 11ÀÏ 12:20~13:00 ½Ä»ç ( )

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 13:00~13:30 Â÷¼¼´ë CAR-T °³¹ß Àü·« ÃÖ°æÈ£(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈ­Çб³½Ç)

±³À°½Ã°£ 11¿ù 11ÀÏ ¸ÞµðÈúȦ (½Å°ü 5Ãþ) 13:30~14:00 ±Þ¼º °ñ¼ö¼º¹éÇ÷º´¿¡¼­ CAR-T Àû¿ë Á¶º´½Ä(¼­¿ï¼º¸ðº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â °í·Á´ëÇб³ ¾È¾Ïº´¿ø CAR-TÇ×¾ÏÄ¡·á ½ÉÆ÷Áö¾ö : 2023-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¶¼±´ëÇб³º´¿ø Á¶¼± À§Àå°ü ¿Ü°ú ½ÉÆ÷Áö¾ö 2023 : 2023-11-11
´ÙÀ½±Û ´ëÇѽ½°üÀýÇÐȸ 2023 7th Veterans Patellofemoral Arthrosis Symposium : 2023-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20987 ¼­¿ï 2024³â Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 72 2024-06-16
20986 ¼­¿ï 2024 ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ ³ú½Å°æÁ¶Àý Moving Symposium : 2024-06-22 0 73 2024-06-16
20985 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 96 2024-06-14
20984 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 62 2024-06-14
20983 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 39 2024-06-14
20982 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 98 2024-06-14
20981 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 78 2024-06-14
20980 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 16 2024-06-14
20979 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 85 2024-06-14
20978 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 112 2024-06-14
20977 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 79 2024-06-14
20976 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 122 2024-06-14
20975 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 50 2024-06-14
20974 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 84 2024-06-14
20973 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 107 2024-06-14
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷